Medical monitoring

New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients

Retrieved on: 
Monday, September 6, 2021

Noting the importance of optimizing preoxygenation in patients needing ETI, the researchers sought to evaluate whether ORi could provide early warning of impending hypoxemia during the procedure, because ORi supplies information beyond the range explored by SpO2.

Key Points: 
  • Noting the importance of optimizing preoxygenation in patients needing ETI, the researchers sought to evaluate whether ORi could provide early warning of impending hypoxemia during the procedure, because ORi supplies information beyond the range explored by SpO2.
  • Secondarily, the investigators evaluated whether a decline in ORi during preoxygenation predicted the occurrence of mild hypoxemia during ETI.
  • The inclusion criteria for this study were ICU admission with a need for ETI and an SpO2/FiO2 ratio above 214.
  • Oxygen reserve index for noninvasive early hypoxemia detection during endotracheal intubation in intensive care: the prospective observational NESOI study.

VyTrac Announces Digital Health Influencer and FINN Global Health Chair Gil Bashe To Join as Strategic Advisor

Retrieved on: 
Wednesday, August 4, 2021

LOS ANGELES, Aug. 4, 2021 /PRNewswire/ -- VyTrac Health, Inc. (VyTrac), a leader in Remote Patient Monitoring (RPM) digital health technologies, announced today that Gil Bashe, Global Health Chair, FINN Partners, is joining its corporate strategic advisory board.

Key Points: 
  • LOS ANGELES, Aug. 4, 2021 /PRNewswire/ -- VyTrac Health, Inc. (VyTrac), a leader in Remote Patient Monitoring (RPM) digital health technologies, announced today that Gil Bashe, Global Health Chair, FINN Partners, is joining its corporate strategic advisory board.
  • Bashe has long been a champion for health innovations that can improve people's health and support access to care.
  • VyTrac provides an easily accessible encrypted health technology platform that enables people to be engaged and participate in their health management.
  • VyTrac Health, Inc. is on the forefront of innovation and technology empowering providers to better manage their patients' health remotely.

Assure Holdings Performs First Neuromonitoring Case in Nebraska

Retrieved on: 
Thursday, July 29, 2021

DENVER, July 29, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has performed its first neuromonitoring case in the state of Nebraska.

Key Points: 
  • DENVER, July 29, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has performed its first neuromonitoring case in the state of Nebraska.
  • Assure is continuing to generate strong organic growth, both by expanding into new states and extending our reach within our current operational footprint.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.
  • Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commissions Gold Seal of Approval.

Global Blood Glucose Monitoring Market Report 2021-2025 - Market is Expected to Increase at a CAGR of 13.8% - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "Diabetes Management: Blood Glucose Monitoring Devices Market (2021)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Diabetes Management: Blood Glucose Monitoring Devices Market (2021)" report has been added to ResearchAndMarkets.com's offering.
  • The burgeoning global blood glucose monitoring market is expected to increase at a healthy CAGR of 13.8%, from nearly $9.1bn in 2019, $9.8bn in 2020, to an estimated $19.7bn in 2025.
  • The blood glucose monitoring devices market includes: conventional handheld blood glucose meters (BGMs) that require frequent fingersticks, and new, sensor-based continuous glucose monitoring systems (CGMs) typically worn the upper arm or abdomen that conveniently monitor blood glucose 24/7, as well as lucrative supplies and software/accessories.
  • This comprehensive medical market and technology report provides:
    In-depth market and competitive analyses (market drivers/limiters, 6-year market forecasts by segment and region, 2019 and 2020 global/regional market share)

Global Ambulatory Cardiac Monitoring Devices Market (2021 to 2031) - Industry Analysis, Size, Share, Growth, Trends and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 28, 2021

The report also provides the compound annual growth rate (CAGR) of the global ambulatory cardiac monitoring devices market for the forecast period.

Key Points: 
  • The report also provides the compound annual growth rate (CAGR) of the global ambulatory cardiac monitoring devices market for the forecast period.
  • Additionally, the report sheds light on the changing competitive dynamics in the global ambulatory cardiac monitoring devices market.
  • ), top three players operating in the market, and COVID-19 pandemic impact on the global ambulatory cardiac monitoring devices market.
  • Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global ambulatory cardiac monitoring devices market report.

BIOTRONIK's Implantable Cardiac Monitor Receives Prestigious Industry Award

Retrieved on: 
Wednesday, July 28, 2021

"By allowing patients' recorded cardiac rhythm disturbance to be automatically and wirelessly transmitted to physicians, the solution enables 24-hour monitoring from anywhere.

Key Points: 
  • "By allowing patients' recorded cardiac rhythm disturbance to be automatically and wirelessly transmitted to physicians, the solution enables 24-hour monitoring from anywhere.
  • "Such efficacy is useful, especially during the COVID-19 pandemic, as physicians can continually monitor patients for warning signs without hospital visits."
  • Miniaturized implantable cardiac monitor with a long sensing vector (BIOMONITOR III): Insertion procedure assessment, sensing performance, and home monitoring transmission success.
  • Hayes, D, Reddy R and Whittington, H. Correlation of Vital Signs Facilitates Illness Screening in an Implantable Cardiac Monitor.

$22+ Billion Worldwide Cardiac Monitoring & Cardiac Rhythm Management Industry to 2026 - Featuring Berlin Heart, Cardiac Science Corp and LivaNova Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021

The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 22.64 Bn in 2021 and is expected to reach USD 28.62 Bn by 2026, growing at a CAGR of 4.8%.

Key Points: 
  • The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 22.64 Bn in 2021 and is expected to reach USD 28.62 Bn by 2026, growing at a CAGR of 4.8%.
  • The increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market.
  • By Geography, North American region holds the largest share and is the dominating region in the cardiac monitoring and cardiac rhythm management devices market followed by Europe.
  • The report offers a comprehensive evaluation of the Global Cardiac Monitoring & Cardiac Rhythm Management Market.

PaceMate™ and UNC School of Medicine Advance Cardiac Research with Data Partnership

Retrieved on: 
Thursday, July 22, 2021

PaceMate, the leading digital healthcare company in compliant cardiac data management, is pleased to announce a new strategic data research partnership with electrophysiologists, cardiologists, and the department research team at the University of North Carolina School of Medicine.

Key Points: 
  • PaceMate, the leading digital healthcare company in compliant cardiac data management, is pleased to announce a new strategic data research partnership with electrophysiologists, cardiologists, and the department research team at the University of North Carolina School of Medicine.
  • The unmatched breadth of cardiac device data collected via PaceMates unique platformPaceMateLIVEis enabling UNC to perform a more comprehensive and robust follow-on study for their 2016 research correlating election-related stressors with an increase in adverse cardiac events.
  • After reviewing publications citing the deep level of data PaceMate takes in from each monitored cardiac device and after understanding how we stratify that data for easy, efficient queries, UNC recognized the unique capabilities of our platforms data analytics to meaningfully advance their research, Higgins stated.
  • PaceMate is the only company in the cardiac monitoring space generating data insights that are immediately actionable for clinics and for research.

Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

Retrieved on: 
Wednesday, July 21, 2021

PARIS and BOSTON, July 21, 2021 /PRNewswire/ -- Cardiologs , a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the launch of Cardiologs RPM an innovative new solution that unlocks the potential of smartwatches for remote cardiac patient monitoring.

Key Points: 
  • PARIS and BOSTON, July 21, 2021 /PRNewswire/ -- Cardiologs , a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the launch of Cardiologs RPM an innovative new solution that unlocks the potential of smartwatches for remote cardiac patient monitoring.
  • The Cardiologs RPM platform is the company's first venture into the remote patient monitoring space, bringing its foundational ECG analysis tool to a more direct level of patient care with the goal of going beyond the world of arrhythmias.
  • "The unstructured and decentralized flow of clinical information is limiting smartwatches from making their way into clinical practice at scale.
  • Our platform will address these challenges by automating and streamlining the data-sharing and data-reviewing process," said Yann Fleureau, Cardiologs' Co-Founder and CEO.

Insights on the Pulse Oximeter Global Market to 2027 - Featuring Medtronic, CE Healthcare and Masimo Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Pulse Oximeter Market, By Product Type (Fingertip, Handheld and Others), By Sensor Type (Reusable v/s Disposable), By Patient Type (Adult, Pediatric, Neonatal), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The Global Pulse Oximeter Market is segmented by product type, sensor type, patient type end-user, company and regional distribution.
  • To analyze the historical growth in the market size of the Global Pulse Oximeter Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Pulse Oximeter Market from 2021 to 2026 and growth rate until 2026.
  • To identify key sustainable strategies adopted by market players in the Global Pulse Oximeter Market.